Asia Pacific Eye Health Supplements Market By Formulation (Tablets, Capsules, Powder, Softgels, and Liquid), By Indication (Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Inflammation, Cataract and Others), By Ingredient Type (Lutein and Zeaxanthin, Antioxidants, Flavonoids, Alpha-Lipoic Acid, Omega-3 Fatty acids, Coenzyme Q10, Astaxanthin and Others), By Country, Industry Analysis and Forecast, 2020 - 2026
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Asia Pacific Eye Health Supplements Market
The Asia Pacific Eye Health Supplements Market would witness market growth of 11.4% CAGR during the forecast period (2020-2026). Nutrients that are considered beneficial for the health of the eye show different levels of safety and efficacy. Vitamin A is critical for vision as it is a crucial component of rhodopsin, and supplementation of vitamin A is still one of the vital nutritional interventions in emerging areas. Preformed vitamin A is abundantly available in industrialized countries and according to the National Institutes of Health’s Office of Dietary Supplements, its overconsumption may result in accumulation in the liver thus causing significant toxicity. Thus it is advised to take supplements in provitamins-A like beta-carotene.
The existence of a large number of local market players are offering affordable and innovative eye health supplements, and contract manufacturing hubs for eye health supplements are continuously increasing in China, India, and the Philippines, thereby driving the market growth in the region. In addition to it, rising awareness about eye health is also positively impacting the market growth. Moreover, the growing prevalence of eye-related disorders in Asian countries is likely to be a main driver for the market. According to a study published by International Finance Corporation, there is about a 6.0% increase in blindness cases annually only in China, comprising about one-fifth of the global blind population in the country.
Based on Formulation, the market is segmented into Tablets, Capsules, Powder, Softgels, and Liquid. Based on Indication, the market is segmented into Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Inflammation, Cataract and Others. Based on Ingredient Type, the market is segmented into Lutein and Zeaxanthin, Antioxidants, Flavonoids, Alpha-Lipoic Acid, Omega-3 Fatty acids, Coenzyme Q10, Astaxanthin and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include The Nature’s Bounty Co. (The Carlyle Group L.P.), Pfizer, Inc., Alticor Inc. (Amway Corporation), Novartis AG, Kemin Industries, Inc., ZeaVision LLC (EyePromise), EyeScience Labs, LLC, Vitabiotics Ltd., Nutrivein and NutraChamps, Inc.
Scope of the Study
Market Segments Covered in the Report:
- Age-related Macular Degeneration (AMD)
- Dry Eye Syndrome
By Ingredient Type
- Lutein and Zeaxanthin
- Alpha-Lipoic Acid
- Omega-3 Fatty acids
- Coenzyme Q10
- South Korea
- Rest of Asia Pacific
- The Nature’s Bounty Co. (The Carlyle Group L.P.)
- Pfizer, Inc.
- Alticor Inc. (Amway Corporation)
- Novartis AG
- Kemin Industries, Inc.
- ZeaVision LLC (EyePromise)
- EyeScience Labs, LLC
- Vitabiotics Ltd.
- NutraChamps, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free